Heterogeneous response and progression patterns during tarlatamab therapy in relapsed small cell lung cancer.
- DOI
- 10.1016/j.lungcan.2026.109685
- Published
- 2026 Nov 7
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109685,
title = {Heterogeneous response and progression patterns during tarlatamab therapy in relapsed small cell lung cancer.},
author = {Murata S and Yoshida T and Tateishi A and Shinno Y and Matsumoto Y and Mizutani T and Okuma Y and Horinouchi H and Yamamoto N and Goto Y},
year = {2026},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2026.109685},
url = {https://doi.org/10.1016/j.lungcan.2026.109685}
}RIS
TY - JOUR TI - Heterogeneous response and progression patterns during tarlatamab therapy in relapsed small cell lung cancer. AU - Murata S AU - Yoshida T AU - Tateishi A AU - Shinno Y AU - Matsumoto Y AU - Mizutani T AU - Okuma Y AU - Horinouchi H AU - Yamamoto N AU - Goto Y PY - 2026 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2026.109685 UR - https://doi.org/10.1016/j.lungcan.2026.109685 ER -
APA
S, M., T, Y., A, T., Y, S., Y, M., T, M., Y, O., H, H., N, Y., & Y, G. (2026). Heterogeneous response and progression patterns during tarlatamab therapy in relapsed small cell lung cancer.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2026.109685
Source records
- pubmed · retrieved 2026-11-10T12:12:14.818Z